I’m putting £300k into a new portfolio. Here’s one FTSE 100 share I plan to buy

I’m investing a £300,000 windfall into quality shares that pay big dividends to shareholders. This cheap FTSE 100 stock is already on my list.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

As I explained on Monday, my family will soon receive a considerable windfall. I estimate this pleasant surprise to be around £300,000 after tax. This sum will arrive after the 2021/22 tax year begins on 5 April. As we don’t need this money right now, my wife and I plan to invest it to generate dividend income and future capital gains. The majority will be invested in high-quality FTSE 100 shares.

Why buy FTSE 100 stocks?

We will build this new £300k portfolio around large-cap FTSE 100 firms. Why? Because everywhere else I look, I see bubbly markets and frothy prices. Indeed, US stocks look fully priced and tech stocks resemble the euphoria of late 1999. I’d rather play safe than buy into irrationally exuberant valuations.

To young investors and day traders, buying shares in boring FTSE 100 businesses may sound unexciting. But almost 35 years of investing have taught me that boring is good. Boring works. Boring makes me richer. I know many fellow investors who have made multi-millions from long-term, patient investing. But I’ve hardly met any day traders who traded their way to real wealth. In short, experience has taught me that owning great businesses often produces outstanding returns. I just need to buy the right shares at the right price.

The Footsie’s top 12

Given the euphoria in US markets right now, I think bigger is better. When the market takes its next downturn, I’d rather own big, beautiful businesses than smaller, riskier companies. That’s why I’m looking to FTSE 100 heavyweights to generate an additional £12,000 a year of passive income. At Tuesday’s close, these 12 Footsie companies had the largest market values:

  • Unilever £117.4bn
  • AstraZeneca £103.7bn
  • HSBC Holdings £81.1bn
  • Rio Tinto £73.3bn
  • GlaxoSmithKline £70.7bn
  • Diageo £67.7bn
  • British American Tobacco £62.9bn
  • BP £57.1bn
  • Royal Dutch Shell A £56.6bn
  • Royal Dutch Shell B £48.9bn
  • Reckitt Benckiser £46.7bn
  • BHP Group £44.2bn

Which share would I buy today?

I’d happily become a shareholder in any of these 12 FTSE 100 Goliaths. Each company is a leader in its field, generating huge revenues, profits and cash flows. These can then be handed over to shareholders in the form of cash dividends, special payouts and share buybacks. But some of them are facing major challenges at present. So, the one share I would buy today is GlaxoSmithKline (LSE: GSK), for it’s what I call a ‘BBC share’. BBC stands for Big, Beautiful and Cautious — which exactly describes the sort of businesses that I want to own.

For the record, I’ve been a GSK shareholder for almost 30 years. Hence, I know this business very well — and I also saw GSK shares having a terrible 2020. Over the past 12 months, they have dived by almost a quarter (22.7%), making them among the cheapest they’ve been for five years. Their share price recovery may not come quickly, but as a bargain-hunter, I do think this FTSE 100 giant is underpriced today.

On Tuesday, the GSK share price closed just short of 1,410p, valuing this pharma behemoth at £70.7bn. At this price, GSK shares trade on a modest price-to-earnings ratio of 11.1 and a chunky earnings yield of 9%. What’s more, the cash dividend of 80p a share equates to a dividend yield of 5.7%, covered almost 1.6 times by earnings. For me, this is plainly too cheap, so I plan to add more GSK shares to my existing holding as soon as possible!


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Cliffdarcy owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Abstract bull climbing indicators on stock chart
Investing Articles

Could the Chancellor’s Leeds Reforms trigger a bull market for UK stocks?

More competitive lending and greater interest in shares could help kick start growth for UK businesses. But could it also…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

I think this AI stock could double before Palantir

Palantir stock is up almost 100% this year. As a result, it now sports a market cap of $350bn meaning…

Read more »

Elevated view over city of London skyline
Investing Articles

As the FTSE 100 hits an all-time high, is it time to reconsider the S&P 500?

Christopher Ruane explains why a surging FTSE 100 has not yet made him focus more on the potential of S&P…

Read more »

GSK scientist holding lab syringe
Investing Articles

The FTSE 100 sits at a record high. But some stocks still look dirt cheap!

The usually sluggish FTSE 100 is having a surprisingly good year. But our writer feels there are still potential bargains…

Read more »

Close-up of British bank notes
Investing Articles

With a £20k Stocks and Shares ISA, here are 3 ways an investor could target a £2k annual passive income

Our writer thinks there is more than one way to try and skin a cat when it comes to earning…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Up 350% in 3 years but my favourite FTSE growth share is still on a low P/E of just 10!

Harvey Jones can't tear his eyes away from this former penny stock turned growth share superpower. But can it carry…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Up 83% in months, could Micron stock be the next Nvidia?

Chipmaker Micron Technology's stock price has surged by over 80% in just a few months. Could this be a possible…

Read more »

Tesla car at super charger station
US Stock

£1k invested in Tesla stock at the start of the year is currently worth…

Jon Smith reveals the performance of Tesla stock in 2025 and explains why he doesn't believe the move lower is…

Read more »